Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors
-
Published:2023-12-07
Issue:
Volume:
Page:1-13
-
ISSN:0028-3835
-
Container-title:Neuroendocrinology
-
language:en
-
Short-container-title:Neuroendocrinology
Author:
Liu Man,Yu Hang,Chen Luohai,Yang Dequan,Liu Haikuan,Ouyang Juan,Zhang Jiang,Yan Xu,Luo Yanji,Lin Yuan,He Qiao,Chen Minhu,Zhang Ning,Wang Yu
Abstract
<b><i>Introduction:</i></b> The aim of this study was to investigate the role of circulating regulatory T cells (Tregs) as a novel marker associated with liver metastases and treatment response to transarterial embolization (TAE) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). <b><i>Methods:</i></b> Circulating Tregs, defined as the CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>low/−</sup> population, were examined by flow cytometry in peripheral blood mononuclear cells from patients with GEP-NETs. Clinicopathological parameters, radiologic response, and hepatic progression-free survival (hPFS) data were collected. <b><i>Results:</i></b> The association between circulating Tregs and clinicopathological parameters was analyzed in 139 GEP-NET patients. Higher Treg levels were significantly associated with more progressive clinical features, including a higher WHO grade, more advanced TNM stage, and the presence of liver metastases. A Treg level ≥8.015% distinguished between patients with and without liver metastases. Among a cohort of 51 GEP-NET patients who were subjected to TAE for reducing liver metastasis burden, patients with higher Treg levels depicted unfavorable responses and significantly reduced hPFS after TAE treatment. We also revealed that patients with Treg<sup>high</sup> (≥8.975%) displayed significantly shorter median hPFS than patients with Treg<sup>low</sup> (<8.975%). Additionally, after adjusting for other confounding clinical parameters, the association between Tregs and treatment response as well as hPFS remained significant, suggesting that Tregs may have a strong and independent prognostic impact in GEP-NETs. <b><i>Conclusion:</i></b> Our data suggest that circulating Tregs are a novel immunological marker associated with liver metastases and treatment response to TAE in patients with GEP-NETs.
Subject
Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献